JP2013534424A5 - - Google Patents

Download PDF

Info

Publication number
JP2013534424A5
JP2013534424A5 JP2013518760A JP2013518760A JP2013534424A5 JP 2013534424 A5 JP2013534424 A5 JP 2013534424A5 JP 2013518760 A JP2013518760 A JP 2013518760A JP 2013518760 A JP2013518760 A JP 2013518760A JP 2013534424 A5 JP2013534424 A5 JP 2013534424A5
Authority
JP
Japan
Prior art keywords
strand
nucleotides
dsrna
less
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013518760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013534424A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/042810 external-priority patent/WO2012006241A2/en
Publication of JP2013534424A publication Critical patent/JP2013534424A/ja
Publication of JP2013534424A5 publication Critical patent/JP2013534424A5/ja
Pending legal-status Critical Current

Links

JP2013518760A 2010-07-06 2011-07-01 二本鎖rnaによるアンドロゲン受容体の特異的阻害に対する方法と化合物 Pending JP2013534424A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36175910P 2010-07-06 2010-07-06
US61/361,759 2010-07-06
PCT/US2011/042810 WO2012006241A2 (en) 2010-07-06 2011-07-01 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna

Publications (2)

Publication Number Publication Date
JP2013534424A JP2013534424A (ja) 2013-09-05
JP2013534424A5 true JP2013534424A5 (cg-RX-API-DMAC7.html) 2014-08-14

Family

ID=45441760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518760A Pending JP2013534424A (ja) 2010-07-06 2011-07-01 二本鎖rnaによるアンドロゲン受容体の特異的阻害に対する方法と化合物

Country Status (6)

Country Link
US (2) US8927515B2 (cg-RX-API-DMAC7.html)
EP (1) EP2591104A4 (cg-RX-API-DMAC7.html)
JP (1) JP2013534424A (cg-RX-API-DMAC7.html)
AU (1) AU2011276363A1 (cg-RX-API-DMAC7.html)
CA (1) CA2804210A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012006241A2 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100048524A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
EP3062106B1 (en) 2008-04-16 2020-11-11 The Johns Hopkins University Method for determining androgen receptor variants in prostate cancer
US9175291B2 (en) * 2012-10-11 2015-11-03 Isis Pharmaceuticals Inc. Modulation of androgen receptor expression
US9850486B2 (en) 2012-12-14 2017-12-26 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of CKAP5 by double-stranded RNA
CA2904170A1 (en) 2013-03-14 2014-09-25 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
CA2916499A1 (en) 2013-07-03 2015-01-08 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded rna
KR20160058774A (ko) 2013-08-12 2016-05-25 토카이 파마슈티컬, 아이엔씨. 안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커
WO2015179404A1 (en) 2014-05-19 2015-11-26 The Johns Hopkins University Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer
WO2016033114A1 (en) * 2014-08-25 2016-03-03 The Johns Hopkins University Methods and compositions related to prostate cancer therapeutics
AU2015367378A1 (en) 2014-12-17 2017-06-15 Proqr Therapeutics Ii B.V. Targeted RNA editing
US10920240B2 (en) 2015-07-30 2021-02-16 Basf Agricultural Solutions Seed, Us Llc Methods and compositions for the control of rust fungi by inhibiting expression of the HXT1 gene
MA45340A (fr) * 2016-04-01 2019-02-06 Avidity Biosciences Llc Acides nucléiques du récepteur des androgènes et leurs utilisations
EP3475424A1 (en) 2016-06-22 2019-05-01 ProQR Therapeutics II B.V. Single-stranded rna-editing oligonucleotides
WO2018041973A1 (en) * 2016-09-01 2018-03-08 Proqr Therapeutics Ii B.V. Chemically modified single-stranded rna-editing oligonucleotides
US20180193270A1 (en) 2016-11-29 2018-07-12 PureTech Health LLC Exosomes for delivery of therapeutic agents
US11274300B2 (en) 2017-01-19 2022-03-15 Proqr Therapeutics Ii B.V. Oligonucleotide complexes for use in RNA editing
KR102321426B1 (ko) * 2017-02-21 2021-11-05 올릭스 주식회사 남성형 탈모 표적 유전자의 발현을 억제하는 비대칭 siRNA
US20200399681A1 (en) * 2018-02-23 2020-12-24 Cornell University Assay for detection of androgen receptor variants
ES2959701T3 (es) 2018-03-27 2024-02-27 Univ Rochester Moléculas de ácido nucleico para pseudouridilación
GB201808146D0 (en) 2018-05-18 2018-07-11 Proqr Therapeutics Ii Bv Stereospecific Linkages in RNA Editing Oligonucleotides
KR102473989B1 (ko) * 2018-11-28 2022-12-07 (주)바이오니아 안드로젠 수용체 특이적 서열을 포함하는 이중나선 올리고뉴클레오티드 구조체, 및 이를 포함하는 탈모 예방 및 발모용 조성물
AU2025213169A1 (en) * 2024-01-24 2026-07-23 Arrowhead Pharmaceuticals, Inc. Rnai agents for inhibiting expression of androgen receptor (ar), compositions thereof, and methods of use
WO2025226946A1 (en) * 2024-04-24 2025-10-30 Cedric Francois Methods and compositions for the treatment of androgenic alopecia
JPWO2025254047A1 (cg-RX-API-DMAC7.html) * 2024-06-06 2025-12-11

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050170371A1 (en) * 2001-05-18 2005-08-04 Sirna Therapeutics, Inc. RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
US20060257851A1 (en) * 2002-11-26 2006-11-16 Itzhak Bentwich Bioinformatically detectable group of novel viral regulatory genes and uses thereof
US20050164970A1 (en) * 2003-12-22 2005-07-28 University Of Kansas Medical Center Method for treating prostate cancer using siRNA duplex for androgen receptor
CA2559955C (en) 2004-03-15 2016-02-16 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded rna
US20070265220A1 (en) 2004-03-15 2007-11-15 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
JP4961549B2 (ja) * 2006-02-16 2012-06-27 国立大学法人愛媛大学 アンドロゲン受容体遺伝子に特異的なsiRNA
US20080014584A1 (en) * 2006-06-01 2008-01-17 Mayo Foundation For Medical Education And Research Modulating androgen receptor activity

Similar Documents

Publication Publication Date Title
JP2013534425A5 (cg-RX-API-DMAC7.html)
JP6236498B2 (ja) 非対称性干渉rnaの組成物およびその使用
RU2013148024A (ru) Композиции и способы ингибирования экспрессии гена tmprss6
JP2007529224A5 (cg-RX-API-DMAC7.html)
US20110196019A1 (en) Treatment of Cancer by Inhibition of IGFBPs and Clusterin
SG170780A1 (en) Compositions and methods for inhibiting expression of eg5 gene
JP2014097072A5 (cg-RX-API-DMAC7.html)
SG171676A1 (en) Compositions and methods for inhibiting expression of the pcsk9 gene
WO2008109452B1 (en) Nucleic acid compounds for inhibiting tie gene expression and uses thereof
JP2011505833A5 (cg-RX-API-DMAC7.html)
CN105008533A (zh) 嵌合单链反义多核苷酸和双链反义试剂
JP2013534424A (ja) 二本鎖rnaによるアンドロゲン受容体の特異的阻害に対する方法と化合物
JP2010532163A5 (cg-RX-API-DMAC7.html)
CN102719432B (zh) 特异性抑制肿瘤凋亡抑制基因Bcl2的双链不对称小核酸干扰分子asiRNA及其应用
US11072795B2 (en) Antisense oligonucleotides
US11118184B2 (en) Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene
JP2024512635A5 (cg-RX-API-DMAC7.html)
JP2007530431A5 (cg-RX-API-DMAC7.html)
CN118103508A (zh) 心血管疾病的治疗
EP2064328B1 (en) Sensitization of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
WO2025016342A1 (zh) 靶向血管紧张素原的寡核苷酸及其用途
KR101993377B1 (ko) Bcl2 유전자 및 bi-1 유전자의 발현을 동시에 억제하는 핵산
CN118510894A (zh) 用于抑制前激肽释放酶(pkk)蛋白表达的组合物和方法
CN107709561A (zh) 修饰的siRNA及含有该修饰的siRNA的药物组合物
CN101173275B (zh) 抑制sars冠状病毒m蛋白基因表达的小干扰rna及其编码基因与应用